Image_3_No Evidence for a Decrease in Physical Activity Among Swiss Office Workers During COVID-19: A Longitudinal Study.PDF by Andrea Martina Aegerter (10127111)

“…Weak statistical evidence for a decline in total physical activity in metabolic equivalent of task minutes per week (MET min/week) was found (estimate = −292, 95% CI from – ∞ to 74, p-value = 0.09), with no evidence for a decrease in the three types of activity: walking (estimate = −189, 95% CI from – ∞ to 100, p-value = 0.28), moderate-intensity activity (estimate = −200, 95% CI from – ∞ to 30, p-value = 0.22) and vigorous-intensity activity (estimate = 80, 95% CI from – ∞ to 460, p-value = 0.74). …”

Image_1_No Evidence for a Decrease in Physical Activity Among Swiss Office Workers During COVID-19: A Longitudinal Study.TIFF by Andrea Martina Aegerter (10127111)

“…Weak statistical evidence for a decline in total physical activity in metabolic equivalent of task minutes per week (MET min/week) was found (estimate = −292, 95% CI from – ∞ to 74, p-value = 0.09), with no evidence for a decrease in the three types of activity: walking (estimate = −189, 95% CI from – ∞ to 100, p-value = 0.28), moderate-intensity activity (estimate = −200, 95% CI from – ∞ to 30, p-value = 0.22) and vigorous-intensity activity (estimate = 80, 95% CI from – ∞ to 460, p-value = 0.74). …”

Presentation_1_No Evidence for a Decrease in Physical Activity Among Swiss Office Workers During COVID-19: A Longitudinal Study.pdf by Andrea Martina Aegerter (10127111)

“…Weak statistical evidence for a decline in total physical activity in metabolic equivalent of task minutes per week (MET min/week) was found (estimate = −292, 95% CI from – ∞ to 74, p-value = 0.09), with no evidence for a decrease in the three types of activity: walking (estimate = −189, 95% CI from – ∞ to 100, p-value = 0.28), moderate-intensity activity (estimate = −200, 95% CI from – ∞ to 30, p-value = 0.22) and vigorous-intensity activity (estimate = 80, 95% CI from – ∞ to 460, p-value = 0.74). …”

Decreased Serum Level of miR-146a as Sign of Chronic Inflammation in Type 2 Diabetic Patients by Lucy Baldeón R. (674016)

“…<div><p>Background</p><p>There is increasing evidence that chronic inflammation is an important determinant in insulin resistance and in the pathogenesis of type 2 diabetes (T2D). MicroRNAs constitute a newly discovered system of cell regulation and in particular two microRNAs (miR-146a and miR-155) have been described as regulators and biomarkers of inflammation.…”

Ang 1–7 decreased Ang II-stimulated ER stress. by Dharmani Murugan (841819)

Regenerating axons are increased by ATRA and decreased by clodronate. by Valeria De La Rosa-Reyes (6658613)

“…<p>(A—E) Confocal images of immunohistochemical staining of growing axons with anti-GAP43 antibody (green), in longitudinal sections of the optic nerve at 2 weeks after axotomy. …”

Twenty-four hour monitoring revealed increased interaction and decreased activity during daytime in <i>Cdkl5</i> -/Y mice. by Kosuke Okuda (5150393)

“…The genotype difference during the whole period was significant (p = 0.0012). (ii) Activity level (A.U.). The activity level of <i>Cdkl5</i> -/Y mice is significantly decreased compared to <i>Cdkl5</i> +/Y mice during daytime (p = 0.0004), but not in the nighttime (p = 0.1535). …”

Combined EGCG/As decreases the viability of two types of EC, HUVEC and HBMEC. by Jee-Youn Kim (796526)

Transduction of Gsx2 decreases the capacity of OBSCs to differentiate into astrocytes and oligodendrocytes. by Héctor R. Méndez-Gómez (189198)

Inhibition of inflammatory signalling pathways decreases HSV-2 viral shedding. by Victor H. Ferreira (719813)

Injection of pNaKtide diminishes PNx-induced decrease in miR-29b-3p expression. by Christopher A. Drummond (3845110)

RV-decreases IRAK-1 protein via TLR2 activation. by Benjamin L. Unger (130418)

Resuscitation with AVP restores the mean arterial blood pressure. by Carrie A. Sims (4532332)

Effects of CGP54626 on NPY^G2WT neurons. by Youjin Oh (3308670)

GSK343 decreased viability and proliferation in human neuroblastoma PDX cells. by Laura V. Bownes (10276762)

“…GSK343 treatment resulted in significantly decreased viability. (B) COA3 and COA6 (1.5 × 10³) cells were treated with increasing concentrations of GSK343 (0, 5, 15, 25 μM) for 24 hours and proliferation was measured using CellTiter^® assay. …”

25OHD₃ increases expression of TRPV6 and Calbindin-D9k in duodenum of CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

25OHD₃ does not induce vascular calcification in CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

25OHD₃ restores calcium and PTH levels in CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

The effect of 25OHD3 on the expression of renal PMCA1b and NCX1 in CYP27B1^+/+ and CYP27B1^-/- mice. by Noelia Torremadé (3687523)

25OHD₃ increases expression of CalbindinD-28K in the kidneys of CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)